SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the latest release of its unified biology assay and study management software suite consisting of Accelrys BioRails DM 4.5, Accelrys BioRails PTO 4.5 and Accelrys Morphit 3.0. The Accelrys BioRails assay data management and project tracking/optimization applications together with the powerful Morphit spreadsheet application help improve the efficiency and productivity of research and development scientists engaged in early-stage screening through in vitro ADME, in vivo DMPK and pharmacology experiments. In the latest BioRails releases, deeper integration with the Accelrys Enterprise Platform and Accelrys Pipeline Pilot extends the data processing and reporting capabilities of BioRails, significantly improving personal and project team productivity in bringing new drugs to market.
"Coordinating and tracking study designs for lead optimization of small molecule and biotherapeutics drugs is a challenge today that leads to inefficient delivery of results, slow turnaround times, costly bottlenecks and poor decision transparency across organizational and geographic boundaries," said Adel Laoui, PhD, managing director of the Accelrys Life Sciences R&D segment. "The latest releases of the Accelrys BioRails and Morphit applications offer a comprehensive, scalable software solution with true integration of different biopharmaceutical data types, enabling scientists to efficiently manage, analyze and share structured bioassay data during multi-domain drug optimization."
Accelrys BioRails DM (Data Management) and
|SOURCE Accelrys, Inc.|
Copyright©2012 PR Newswire.
All rights reserved